GlassScriptPhysician profile
Ashley M Smith
NPI 1215480561
$3,293.98
in general payments reported to CMS, 2019-2025
27 companies · $1,365 in 2025
The $1,365 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $243 · 2023: $666 · 2024: $920 · 2025: $1,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,950.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $642.98 | 2022-2025 | |
| Abbvie INC. | $454.39 | 2022-2025 | |
| Abbott Laboratories | $339.32 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.55 | 2021-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $226.97 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $220.38 | 2023-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $170.48 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $133.70 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $121.91 | 2021-2025 | Farxiga, Airsupra |
| Hologic Sales and Service, LLC | $77.66 | 2023-2025 | Thinprep 2000 Processor, Aptima |
| Dexcom, INC. | $77.02 | 2021-2023 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $75.36 | 2025 | Sunosi |
| Glaxosmithkline, LLC. | $60.49 | 2021-2025 | Shingrix, Arexvy |
| Avadel Cns Pharmaceuticals, LLC | $57.77 | 2024-2025 | Lumryz |
| Bayer Healthcare Pharmaceuticals INC. | $49.42 | 2022-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $46.37 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $41.59 | 2022 | |
| Daiichi Sankyo INC. | $38.51 | 2025 | Injectafer |
| Harmony Biosciences LLC | $29.48 | 2024 | |
| Cvrx, INC. | $26.87 | 2024 | Barostim Neo System |
| Baxter Healthcare | $25.10 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi Pasteur INC. | $24.94 | 2023 | |
| Phathom Pharmaceuticals, INC. | $22.36 | 2025 | Voquezna |
| Medtronic, INC. | $21.27 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $20.07 | 2025 | Neffy |
| Inspire Medical Systems, INC. | $17.39 | 2025 | Inspire |
| Shield Therapeutics INC | $13.63 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.